Opportunity Information: Apply for RFA DK 11 026
Apply for RFA DK 11 026
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Dec 6, 2011 and posted on Dec 6, 2011.
- Applicants must submit their applications by Mar 14, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,250,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities State governments Special district governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity RFA-DK-11-026, titled "Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) (U01)," was a discretionary grant announcement issued by the National Institutes of Health to establish a cooperative research network focused on lower urinary tract dysfunction (LUTD). The goal of the LURN initiative was to improve how LUTD is measured and described in both men and women by creating and qualifying symptom-based measurement tools and by developing clearer, more clinically meaningful patient phenotypes. In practical terms, the program aimed to move beyond broad or imprecise labels and instead capture the real-world patterns of urinary symptoms as they appear over time, including symptoms that are early or late in the course of illness, short-lived (transient), or long-lasting (persistent).
A central purpose of the network was the development and qualification of symptom-based instruments, meaning structured tools (often questionnaires or standardized assessments) designed to reliably measure patient-reported urinary symptoms. The emphasis on qualifying these instruments signals a push for rigorous testing so that the tools are not only well designed but also validated for consistency, sensitivity to change, and usefulness across different patient groups. Because LUTD symptoms can vary widely by sex, age, and underlying causes, the FOA explicitly targeted measurement approaches applicable to both males and females, helping ensure that resulting instruments and definitions would not be limited to one population or a single clinical presentation.
Another major objective was to "better define the phenotypes" of individuals with LUTD. Phenotyping in this context refers to identifying distinct subgroups of patients based on symptom patterns, severity, timing, and persistence, potentially integrating clinical characteristics and other measurable features. The overall direction of the announcement suggests NIH wanted a network capable of systematically collecting comparable data across sites, analyzing symptom clusters, and producing refined categories that could be used in research and, eventually, to guide more tailored clinical care. Better phenotypes can improve research studies by ensuring that participants are grouped in ways that reflect meaningful biological or clinical differences, rather than being lumped together under overly broad diagnoses.
This opportunity used the U01 mechanism, which is a cooperative agreement. That indicates NIH anticipated having substantial programmatic involvement, with NIH staff working collaboratively with awardees rather than operating purely as a hands-off funder. Cooperative agreements are commonly used when the agency wants to coordinate activities across multiple sites, harmonize protocols, and ensure shared milestones and data standards. The FOA anticipated making about four awards, with an estimated total funding level of $1,250,000 and an award ceiling of $250,000. The announcement stated there was no cost sharing or matching requirement, reducing the need for applicants to bring non-federal funds to the project.
The program was associated with CFDA number 93.847, which corresponds to Diabetes, Digestive, and Kidney Diseases Extramural Research, aligning with NIH's NIDDK mission area where urinary tract and related disorders are often housed. The activity category is listed under health, reflecting the biomedical and clinical research focus rather than service delivery or infrastructure-only projects. The FOA was posted on December 6, 2011, with an original and current closing date of March 14, 2012, and an archive date of April 14, 2012, indicating it was a time-limited competition that is now closed.
Eligibility was broad and inclusive. Eligible applicants included many types of U.S. government entities (state, county, city/township, special district governments), public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits), small businesses, and for-profit organizations other than small businesses. The FOA also explicitly included a wide range of mission-driven and community-connected institutions such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions. Notably, non-U.S. entities (foreign institutions) were eligible to apply, and foreign components of U.S. organizations were allowed consistent with NIH policy, which can be important for assembling the best expertise or for including diverse populations in symptom research.
For anyone seeking the original full text, NIH provided an additional information link to the archived FOA page on the NIH grants site. For technical issues accessing the announcement or resolving link problems, the contact point listed was the NIH Office of Extramural Research (OER) Webmaster via FBOWebmaster@OD.NIH.GOV. Overall, the LURN (U01) opportunity was designed to build a coordinated, multi-site research effort capable of producing standardized, validated symptom measurement tools and more precise patient phenotypes, with the broader aim of improving the science underlying LUTD diagnosis, classification, and future treatment research.
Frequently Asked Questions (FAQs)
What is the NIH funding opportunity RFA-DK-11-026?
RFA-DK-11-026 is an NIH discretionary grant announcement titled "Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) (U01)." It was issued to establish a cooperative, multi-site research network focused on improving how lower urinary tract dysfunction (LUTD) symptoms are measured, described, and grouped into clinically meaningful categories.
What does LURN stand for, and what was it intended to do?
LURN stands for the Symptoms of Lower Urinary Tract Dysfunction Research Network. The initiative was intended to improve the science of LUTD by developing and qualifying symptom-based measurement tools and by defining clearer, more clinically meaningful patient phenotypes based on real-world symptom patterns over time.
What is the main goal of this funding opportunity?
The main goal was to move beyond broad or imprecise LUTD labels by creating standardized ways to measure urinary symptoms and by developing better-defined patient phenotypes that reflect actual symptom patterns, severity, timing, and persistence.
What types of research activities did the FOA emphasize?
The FOA emphasized two major areas: (1) development and qualification of symptom-based instruments (structured tools such as questionnaires or standardized assessments) and (2) improved phenotyping of LUTD (identifying distinct patient subgroups based on symptom patterns and related characteristics).
What are "symptom-based measurement tools" in this context?
In this FOA, symptom-based measurement tools refer to structured instruments designed to measure patient-reported urinary symptoms in a consistent, standardized way. These tools are often questionnaires or standardized assessments intended to capture symptom patterns as patients experience them.
What does it mean to "qualify" or validate these symptom-based instruments?
The FOA highlighted qualification as a rigorous process to ensure the instruments are well designed and tested. Based on the description provided, this includes demonstrating consistency, sensitivity to change, and usefulness across different patient groups.
Why did the FOA focus on improving measurement of LUTD symptoms?
The FOA indicated that LUTD symptoms can vary widely by sex, age, and underlying causes. Improving measurement was intended to produce tools that capture real-world symptom patterns, including symptoms that may be early or late in illness, transient (short-lived), or persistent (long-lasting).
Was the research intended to include both men and women?
Yes. The FOA explicitly targeted measurement approaches applicable to both males and females so resulting instruments and definitions would not be limited to a single population or one clinical presentation.
What does "phenotyping" mean in this grant opportunity?
Phenotyping, as described in the FOA, refers to defining distinct subgroups of individuals with LUTD based on symptom patterns, severity, timing, and persistence, potentially integrating clinical characteristics and other measurable features.
How would better phenotypes help LUTD research?
The FOA’s rationale was that better phenotypes can improve research by grouping participants in ways that reflect meaningful biological or clinical differences rather than combining people under overly broad diagnoses. This can support clearer analyses and more informative study results.
What is the funding mechanism used for this opportunity?
This opportunity used the U01 mechanism, which is a cooperative agreement.
What does a U01 cooperative agreement imply about NIH involvement?
A U01 indicates substantial NIH programmatic involvement. The FOA anticipated NIH staff would work collaboratively with awardees to help coordinate activities across multiple sites, harmonize protocols, and support shared milestones and data standards.
How many awards were expected under this FOA?
The FOA anticipated making about four awards.
What was the estimated total funding level and award ceiling?
The FOA listed an estimated total funding level of $1,250,000 and an award ceiling of $250,000.
Was cost sharing or matching required?
No. The FOA stated there was no cost sharing or matching requirement.
Which NIH area or program classification was associated with this opportunity?
The FOA was associated with CFDA number 93.847, described as Diabetes, Digestive, and Kidney Diseases Extramural Research, aligning with NIH’s NIDDK mission area where urinary tract and related disorders are often housed.
What is the activity category for this funding opportunity?
The activity category was listed under health, indicating a biomedical and clinical research focus.
When was the FOA posted, and what were the closing and archive dates?
The FOA was posted on December 6, 2011. The original and current closing date was March 14, 2012. The archive date was April 14, 2012.
Is this funding opportunity currently open?
No. The competition was time-limited and is now closed based on the listed closing and archive dates.
Who was eligible to apply?
Eligibility was broad. Eligible applicants included U.S. government entities (state, county, city/township, special district), public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3)), small businesses, and for-profit organizations other than small businesses.
Were mission-driven and community-connected institutions explicitly included?
Yes. The FOA explicitly included organizations such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions.
Could foreign (non-U.S.) institutions apply?
Yes. The FOA stated that non-U.S. entities (foreign institutions) were eligible to apply.
Were foreign components of U.S. organizations allowed?
Yes. The FOA allowed foreign components of U.S. organizations consistent with NIH policy.
Why might a network approach be important for this topic?
The FOA’s description suggests a network approach helps collect comparable data across sites, analyze symptom clusters, and produce refined categories, supported by harmonized protocols and shared data standards.
Where could applicants find the original FOA text?
NIH provided an additional information link to the archived FOA page on the NIH grants site.
Who was listed as the contact for technical issues accessing the announcement?
For technical issues (such as accessing the announcement or resolving link problems), the FOA listed the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: BJA FY 12 Justice and Mental Health Collaboration Training and Technical Assistance Program
Previous opportunity: Strengthening Political Accountability and Civic Engagement in Moldova (SPACE Moldova) Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 11 026
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 11 026) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Centers for Interdisciplinary Research in Benign Urology (IR BU) (P20) Apply for RFA DK 12 003 Funding Number: RFA DK 12 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Limited Competition for the Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) Apply for RFA DK 12 503 Funding Number: RFA DK 12 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition Continuation of the Clinical Islet Transplantation (CIT) Consortium Data Coordinating Center (U01) Apply for RFA DK 12 501 Funding Number: RFA DK 12 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Nutrition Obesity Research Centers (P30) Apply for RFA DK 12 004 Funding Number: RFA DK 12 004 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01) Apply for RFA DK 11 032 Funding Number: RFA DK 11 032 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Limited Competition for Data Coordinating Center (DCC) for NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U01) Apply for RFA DK 11 502 Funding Number: RFA DK 11 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $900,000 |
| The Collaborative Islet Transplantation Registry (UC4) Apply for RFA DK 12 002 Funding Number: RFA DK 12 002 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $530,000 |
| NIDDK Short Term Education Program for Underrepresented Persons (STEP UP) (R25) Apply for RFA DK 12 005 Funding Number: RFA DK 12 005 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $158,000 |
| The Human Islet Distribution Coordinating Center (UC4) Apply for RFA DK 12 001 Funding Number: RFA DK 12 001 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Apply for PA 12 125 Funding Number: PA 12 125 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21) Apply for PA 12 157 Funding Number: PA 12 157 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Translational Research to Improve Obesity and Diabetes Outcomes (R18) Apply for PAR 12 172 Funding Number: PAR 12 172 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Planning Grants for Translational Research to Improve Obesity and Diabetes Outcomes (R34) Apply for PAR 12 173 Funding Number: PAR 12 173 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Promoting Organ and Tissue Donation Among Diverse Populations (R01) Apply for RFA DK 12 006 Funding Number: RFA DK 12 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Limited Competition for the Continuation of the Halt Polycystic Kidney Disease Trials Data Coordinating Center (DCC) (U01) Apply for RFA DK 12 505 Funding Number: RFA DK 12 505 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01) Apply for RFA DK 12 502 Funding Number: RFA DK 12 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 12 211 Funding Number: PA 12 211 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Kidney Research Core Centers (P30) Apply for RFA DK 12 008 Funding Number: RFA DK 12 008 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Research Enhancement for NIDDK Hematology Grantees (Admin Supp) Apply for PA 12 242 Funding Number: PA 12 242 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44) Apply for PA 12 258 Funding Number: PA 12 258 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 11 026", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
